CHG-2024-0277
New Dosage Strength for Neuravastatin. Facility Change for Neuravastatin — critical change. Impacts 7 markets and 1 variations.
Change Number
CHG-2024-0277
Type
New Dosage Strength
Product
Status
Blocked
Owner
Priya Sharma
Initiated
2023-03-13
Description
Facility Change for Neuravastatin — critical change
Impacted Markets (7)
US — United StatesCH — SwitzerlandDE — GermanyTW — TaiwanMX — MexicoTR — TurkeyBE — Belgium
Impacted Modules
2.3.P5.3.53.2.S
Linked Variations (0)
| Variation # | Type | Application | Status | Submitted | Approved |
|---|